LEADER 03902nam  22005175  450 
001 9910254465003321
005 20200706082242.0
010   $a3-319-51673-6
024 7 $a10.1007/978-3-319-51673-8
035   $a(CKB)3710000001124871
035   $a(DE-He213)978-3-319-51673-8
035   $a(MiAaPQ)EBC4831867
035   $a(PPN)199769885
035   $a(EXLCZ)993710000001124871
100   $a20170327d2017      u|         0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPharmaceutical Policy in Countries with Developing Healthcare Systems /$fedited by Zaheer-Ud-Din Babar
205   $a1st ed. 2017.
210  1$aCham :$cSpringer International Publishing :$cImprint: Adis,$d2017.
215   $a1 online resource (XII, 430 p. 36 illus., 33 illus. in color.)
311   $a3-319-51672-8 
320   $aIncludes bibliographical references at the end of each chapters.
327   $a1. Introduction -- Section I: Low and Lower Middle Income Countries -- 2. Pharmaceutical Policy in the East African Community: Burundi, Kenya, Uganda, Rwanda, Tanzania -- 3. Pharmaceutical Policy in Pakistan -- 4. Pharmaceutical Policy in Philippines -- 5. Pharmaceutical Policy in Vietnam -- Section II: Upper Middle Income Countries -- 6. Pharmaceutical Policy in Argentina -- 7. Pharmaceutical Policy in Brazil -- 8. Pharmaceutical Policy In Bulgaria -- 9. Pharmaceutical Policy in China -- 10. Pharmaceutical Policy in Colombia -- 11. Pharmaceutical Policy in Ecuador -- 12. Pharmaceutical Policy in Jordan -- 13. Pharmaceutical Policy in Russia -- 14. Pharmaceutical Policy in South Africa -- Section III: High Income Countries -- 15. Pharmaceutical Policy in Poland -- 16. Pharmaceutical Policy in Saudi Arabia -- 17. Pharmaceutical Policy in Trinidad and Tobago -- 18. Pharmaceutical Policy in United Arab Emirates -- Section IV: Further Perspectives -- 19. ?Repurposing? Medicines: a Case for Low- and Middle-Income Countries with Developing Healthcare Systems -- 20. Pharmaceutical Policy in Countries with Developing Healthcare Systems: Synthesis of Country Case Studies.
330   $aA comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common format, beginning with an overview of the health system and regulatory and policy environments, before discussing the difficulties in maintaining a medicines supply system, challenges in ensuring access to affordable medicines and issues impacting on rational medicine use. Numerous case studies are also used to highlight key issues and each chapter concludes with country-specific solutions to the issues raised. Written by highly regarded academics, the book includes countries in Africa, Asia, Europe, the Middle East and South America.
606   $aPharmacy
606   $aPublic health
606   $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008
606   $aPublic Health$3https://scigraph.springernature.com/ontologies/product-market-codes/H27002
606   $aScience, Humanities and Social Sciences, multidisciplinary$3https://scigraph.springernature.com/ontologies/product-market-codes/A11007
615  0$aPharmacy.
615  0$aPublic health.
615 14$aPharmacy.
615 24$aPublic Health.
615 24$aScience, Humanities and Social Sciences, multidisciplinary.
676   $a338.45
676   $a362.1782
676   $a615.1
702   $aBabar$b Zaheer-Ud-Din$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910254465003321
996   $aPharmaceutical Policy in Countries with Developing Healthcare Systems$92513554
997   $aUNINA